. Some discrepancies between LICs and HICs* [5] LIC HIC Life expectancy at birth (years) 57. 
The sub-Saharan Africa perspective
According to the WHO, SSA comprises 13% of the world's population. It also carries 24% of the global disease burden, but has only 1% of the global financial resources to do this. SSA's demographics show a young population of whom 40% are <15 years of age. The mortality figures mirror this -80% of all deaths occur in those who are <60 years old. Conversely, in high-income countries (HICs), 80% of deaths occur in those >60 years of age. [6] The cancer patterns seen in SSA are different from those in the developed world. Although the overall cancer incidence is lower than in developed countries, relatively more malignancies are seen in children and young people. The commonest malignancies in women are cervical and breast cancer.
There is a lack of medical personnel in SSA. The WHO recommends that ideally the physician:population ratio should be 50:100 000, while in Africa it is only 18:100 000. More than 100 medical schools in SSA were surveyed; half of these reported losing 6 -8% of their staff in the past 5 years. [7] While the management of cancer requires specialist knowledge, there is a paucity of all types of specialists in SSA. In addition, there are discrepancies within the SSA region, with South Africa (SA) faring better than its neighbours. In this regard, it should be noted that SA is essentially an MIC, but due to the gross disparities in socioeconomic class it is effectively both an HIC and a LIC. For example, in Uganda there are 10 specialist anaesthetists [8] compared with 800 in SA (I Buccimazza -unpublished data, 2008) ( Fig. 1) .
Not only are specialist resources scarce, but support services and essential medications are also lacking. Half of those who die from HIV need active pain management during the last 3 months of their life, while 80% of those who die from cancer need pain medication. Yet, access to oral morphine is available in fewer than 11 African countries. [1] 
Breast cancer in South Africa
The precise incidence of breast cancer in SA is unknown. There is no reliable national data registry, and the information available is gleaned from individual units in the larger healthcare centres. It is known that in state healthcare facilities, a significant number of patients present with clinically advanced disease. Treatment options are further compounded by a high incidence of HIV disease.
In a survey, the stage, HIV status and type of breast cancer in 1 200 women who presented to Chris Hani Baragwanath Academic Hospital were documented. Of those tested, 19.7% were HIV-positive, over half presented with locally advanced or metastatic cancer (stage 3 or 4) and 1.5% presented with ductal carcinoma in situ (DCIS). In a screened UK population, nearly 20% of women were diagnosed with DCIS. [9, 10] The management guidelines formulated in HICs are unaffordable, unobtainable and inappropriate for the management of breast cancer in LICs. Sambo et al. [11] have summarised the challenges in cancer management in SSA as follows:
• Absence of cancer prevention, control policy, strategies and programmes. Most experts agree that mammographic screening is unaffordable and breast examination is generally not a good screening modality. However, studies have not tested this premise in countries where most tumours are clinically obvious or advanced at presentation. A Sudanese pilot study by Abuidris et al. [12] showed the potentially beneficial effects of a cancer awareness programme using trained nonmedical volunteers, and suggests that clinical breast examination may be useful in low-resource settings. [13] There is no national breast cancer policy in place, and regional programmes are in their infancy. A greater emphasis needs to be placed on competent diagnostic units to fast track patients with breast cancer to the appropriate centre of care.
• Insufficient recent and comprehensive data for cancer and death registration. For any country to plan a comprehensive health policy, a national register of disease incidence must be kept. The aim is to improve the quality and quantity of graduates, retain specialists and improve research. [14] The African Organisation for Training and Research in Cancer (AORTIC) held a workshop in Durban to discuss ways of retaining specialists in their country of training. [15] • The high cost of immunisation against human papillomavirus and other infections that cause cancer. In SA, the state has recently started a national human papillomavirus immunisation campaign.
• Unavailability of secondary prevention for cancer amenable to this intervention. • Unaffordability of treatment resources and neglect of palliative care. Oral morphine must be made available for use in palliative care.
• Absence of collaboration or co-ordination of interventions with regard to stakeholders and donors to combat cancer. It is imperative that interested stakeholders unite and work towards a common goal.
Conclusion
The incidence of breast cancer will increase significantly in all LICs. SA and its neighbouring countries will be significantly affected. It is therefore imperative that healthcare resources, policies and planning focus on this in a co-ordinated and rational way.
